Drug recall · November 29, 2023
Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL recall
Why: Presence of Particulate Matter: Silicone
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4).
- Lots / codes
Lot # 10001088 exp 07/31/2024
- Quantity
- 23,425 vials
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide
- Initiated
- October 18, 2023 · Voluntary: Firm initiated
- Classified
- November 22, 2023
- Reported
- November 29, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Midazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.